⌘K
Loading ticker…
As of 2026-08-24, Indivior Pharmaceuticals, Inc. Common Stock (INDV) has a 3-month relative strength percentile of 40 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.2%, relative volume 0.73×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
INDV appears in 1 ETF as of Jun 2026: PSC at 0.31% weight, $7M notional.
Held by 91 ETFs · $971M across latest filings · largest weight 2.40% (PSCH).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PSC | 0.31% | $7M | +0.04 pp |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | INDV Jan avg: 3.29% median: -1.39% win: 33% σ: 10.69% n: 3 2023-06-13 → 2026-07-31 | INDV Feb avg: -2.79% median: -7.52% win: 33% σ: 22.30% n: 3 2023-06-13 → 2026-07-31 | INDV Mar avg: -1.25% median: -0.05% win: 33% σ: 5.10% n: 3 2023-06-13 → 2026-07-31 | INDV Apr avg: 7.81% median: 20.67% win: 67% σ: 22.37% n: 3 2023-06-13 → 2026-07-31 | INDV May avg: 4.66% median: 4.33% win: 67% σ: 6.90% n: 3 2023-06-13 → 2026-07-31 | INDV Jun avg: 5.26% median: 9.22% win: 75% σ: 12.40% n: 4 2023-06-13 → 2026-07-31 | INDV Jul avg: 3.31% median: -4.54% win: 25% σ: 23.05% n: 4 2023-06-13 → 2026-07-31 | INDV Aug avg: 3.72% median: 0.04% win: 67% σ: 14.99% n: 3 2023-06-13 → 2026-07-31 (current) | INDV Sep avg: -6.32% median: -0.70% win: 33% σ: 13.76% n: 3 2023-06-13 → 2026-07-31 | INDV Oct avg: -2.03% median: -7.59% win: 33% σ: 21.62% n: 3 2023-06-13 → 2026-07-31 | INDV Nov avg: 10.29% median: 14.40% win: 67% σ: 16.57% n: 3 2023-06-13 → 2026-07-31 | INDV Dec avg: 2.64% median: 6.79% win: 67% σ: 10.93% n: 3 2023-06-13 → 2026-07-31 |